TransEnterix, a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it has expanded distribution of the Senhance Surgical Robotic System.
TransEnterix has partnered with Getz Healthcare to be the exclusive distribution partner for the Senhance in the Australian and New Zealand markets.
“Australia and New Zealand are key markets in the healthcare industry, with leading hospitals and a growing interest in robotic surgery,” said Todd M. Pope, President and CEO at TransEnterix.
“Getz Healthcare is an integrated healthcare distributor with a long track record of success in selling and supporting hospital products. We are excited to partner with such a talented and experienced team in this important region.”
“The Senhance will now be a leading product for our medical device business in Australia and New Zealand,” said James Simkins, CEO of Getz Healthcare.
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options.
The company is focused on the commercialization of the Senhance™ Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control.
The company is also developing the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform.